Latest / Decera Clinical Education Oncology Podcast
Expert Thoughts on Key Trials of Interest for Ovarian and Cervical Cancer at the IGCS 2022 Annual Global Meeting
In this episode,Susana Banerjee, MBBS, MA, PhD, and Mansoor Raza Mirza, MD, share their thoughts on key studies of interested presented at the IGCS 2022 Annual Global Meeting for ovarian and cervical cancers including:
Post-hoc analyses from SOLO-3: olaparib vs physician’s choice chemotherapy in germline BRCA mutant platinum-sensitive recurrent ovarian cancer
Phase III CALLA trial: durvalumab combined with and following chemoradiation for locally-advanced cervical cancer
Phase III ARIEL3: final OS for maintenance rucaparib vs placebo following response to platinum-based chemotherapy for…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.